Liu et al. previously found increased levels of IP-10 in serum and tumor tissue and reduced IP-10 receptors in peripheral blood lymphocytes in patients with HCC, which suggests that lymphocytes became desensitized to the high levels of IP-1023. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.